Peripheral Arterial Disease Trial, Recruiting NCT06231966 Sponsor: Yonsei University Condition: Peripheral Arterial Disease
Back to Peripheral Arterial Disease

Peripheral Arterial Disease Trial, Recruiting

NCT06231966
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged between 19 and 80 years old
  • People who have been diagnosed with hardening of the arteries affecting the blood vessels in the legs — this includes people whose ankle-to-arm blood pressure ratio is below 0.85 with leg pain when walking, people with more than 50% narrowing in a leg artery shown on a scan, or people who have previously had a procedure or surgery to treat leg artery disease
  • People who have hardening of the arteries affecting two or more areas of the body — such as having heart artery disease, a history of significant narrowing of the neck arteries or a stroke or mini-stroke, or a large bulge (aneurysm) in the main artery of the chest or abdomen
  • People who are already taking cholesterol-lowering medication, or people whose LDL ("bad") cholesterol level is 70 mg/dL or higher and who are not currently on cholesterol-lowering medication

Who may not be able to join:

  • People with severe loss of blood flow to a limb that is causing serious tissue damage or wounds (known as critical limb ischemia, Rutherford stages 4–6)
  • People who have had a heart attack, stroke, mini-stroke, or leg amputation within the past 6 months
  • People with active liver disease or significantly elevated liver enzyme levels (more than twice the normal upper limit)
  • People with severely reduced kidney function (eGFR below 30 mL/min/1.73m²) or who are currently on dialysis
  • People who have previously had an allergic reaction or serious side effects from statin or ezetimibe medications that required stopping treatment
  • People who have received a solid organ transplant (such as a kidney, liver, or heart transplant)
  • People who are pregnant, possibly pregnant, or currently breastfeeding
  • People with a life expectancy of less than 3 years
  • People who would not be able to attend follow-up appointments for at least 1 year
  • People who are unable to understand or read the consent form

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 02)-2228-8460

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
22 April 2024
Est. completion
6 May 2026

Where this trial is recruiting

🇰🇷 South Korea

Primary endpoints

Composite of Major cardiovascular event or major adverse limb event

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov